2016 International Congress Archives - Page 30 of 207

12:30pm-2:00pm: Modulation of thalamocortical network dynamics via deep brain stimulation in humans with Tourette syndrome

J.B. Shute, P.J. Rossi, E. Opri, R. Molina, C. De Hemptinne, K.D. Foote, M.S. Okun, A. Gunduz (Gainesville, FL, USA)

Tics/Stereotypies · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Molecular landscape of Parkinson’s disease reveals a key role for lipids and lipoproteins

C.J.H.M. Klemann, G.J.M. Martens, M. Sharma, M.B. Martens, O. Isacson, T. Gasser, J.E. Visser, G. Poelmans (Nijmegen, Netherlands)

Parkinson's disease: Pathophysiology · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Monitoring dyskinesia severity using wearable sensor data

J.F. Daneault, F.N. Golabchi, S.I. Lee, G. Vergara-Diaz, G. Ferreira Carvalho, E. Fabara, S. Sapienza, P. Bonato (Charlestown, MA, USA)

Technology · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Monitoring oxidative stress and progression to cell death: From secretome to blood diagnosis

S.I. Anjo, V.M. Mendes, M. Grãos, B. MAnadas (Cantanhede, Portugal)

Pathophysiology (other movement disorders) · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: mPower: A smartphone-based study of Parkinson’s disease provides personalized measures of disease impact

A.D. Trister, E.C. Neto, B.M. Bot, T. Perumal, A. Pratap, A. Klein, E.R. Dorsey, C.M. Tanner, S.H. Friend (Seattle, WA, USA)

Technology · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: MRI guided high-intensity focused ultrasond for the treatment of essential tremor and Parkinson’s disease: Clinical outcome and radiological findings of unilateral thalamotomy

R. Martínez-Fernandez, J.A. Pineda-Pardo, M. del Álamo, F. Hernández, I. Obeso, S. Casas, P. Pastor, C. Oliver, L. Vela, J.A. Obeso (Madrid, Spain)

Tremor · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Multidisciplinary group program integrating voice and dance movement therapy for Parkinson’s disease patients: Preliminary experience

R. Peled, D. Shpunt, Y. Manor, M. Brozgol, A. Ezra, N. Hezi, R. Hen Simon, J.M. Hausdorff, T. Gurevich (Tel Aviv, Israel)

Parkinson's disease: Pathophysiology · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Muscle selection patterns for injection of onabotulinumtoxinA in adult patients with post-stroke lower-limb spasticity influence outcome: Results from a double-blind, placebo-controlled phase 3 clinical trial

T.H. Wein, A. Esquenazi, A.B. Ward, C. Geis, C. Liu, R. Dimitrova (Montreal, QC, Canada)

Spasticity · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Mutant WDR45 links NBIA to impaired autophagy, mitochondrial dysfunction and oxidative stress

M. Dulovic, S. Zittel, A. Rakovic, A. Westenberger, S. Biskup, A. Münchau, C. Klein, P. Seibler (Belgrade, Serbia)

Rare genetic and metabolic diseases · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Mutational analysis of GNAL gene in isolated dystonia patients from Spain

P. Gómez-Garre, I. Huertas-Fernández, M.T. Cáceres-Redondo, A. Alonso-Canovas, I. Bernal-Bernal, A. Blanco-Ollero, M. Bonilla-Toribio, J.A. Burguera, M. Carballo, F. Carrillo, M.J. Catalán-Alonso, F. Escamilla-Sevilla, R. Espinosa-Rosso, M.C. Fernández-Moreno, J. García-Caldentey, J.M. García-Moreno, S. Giacometti-Silveira, J. Gutiérrez-García, S. Jesús-Maestre, E. López-Valdés, J.C. Martínez-Castrillo, M.P. Medialdea-Natera, C. Méndez-Lucena, A. Mínguez-Castellanos, M. Moya, J.J. Ochoa-Sepúlveda, T. Ojea, N. Rodríguez, I. Rubio-Agusti, M. Sillero-Sánchez, J. del Val, L. Vargas-González, P. Mir (Seville, Spain)

Genetics (NON-PD) · Exhibit Hall located in Hall B, Level 2